Acquisition of Sauflon Pharmaceuticals Limited

  • Acquisition of Sauflon Pharmaceuticals Limited

The Cooper Companies Completes Acquisition of Sauflon Pharmaceuticals Limited

PLEASANTON, Calif., August 6, 2014 — The Cooper Companies, Inc. (NYSE: COO) has completed its acquisition of Sauflon Pharmaceuticals Limited, the manufacturer and distributor of soft contact lenses and solutions. The transaction – valued at approximately $1.2 billion – gives CooperVision the ability to offer the most extensive range of daily disposable contact lens options to eye care practitioners and wearers worldwide.

Eye Care Industry News Release
Investor News Release

View frequently asked questions